Our diverse team members bring with them extensive work experience and expertise in their respective fields. We are dedicated to innovating non-invasive clinical applications for early detection of cancer. We are committed to rigorous testing, data-driven processing, accurate unbiased reporting, and to engineer highly accurate and reliable diagnostic tools. Our goal is to make a significant impact on improving the survivability of cancer.
Thomas Long
CEO, CFO and Cofounder. He drives business direction, approves company strategies, and oversees financial and risk planning activities.
Cherylle Goebel
COO, CSO, Cofounder, and SAB. COO, CSO, Cofounder, and SAB. She directs operational strategies and scientific direction, reviews results, and provides risk assessments.
Christopher Louden
CIO, Cofounder, and SAB. He directs and evaluates statistical approaches for algorithm development and oversees IT operations.
Dorothy Wong, MD, JD
Lab Director
Gerald Weiss, MD
Medical Pathologist
Jyothsna Narla, MD
Medical Pathologist
Jerry Hurst, MA, CLS, CPHM
Technical Supervisor
Caroline Angeles, CLS
General Supervisor
Rachel Chuang, PhD
R&D Director. Dr. Chuang has extensive expertise in Molecular and Cellular Biology. She has more than 26 years of experience in research and developed many assays for gene and protein expression.
Nancy Lim, PharmD
Regulatory Affairs
Scientific Advisory Board
Dr. Robert McKenna, Jr., MD
Dr. McKenna pioneered minimally invasive lung cancer surgery. He has more than 30 years of experience as a thoracic surgeon and over 250 peer reviewed publications.
Dr. Andrew Wachtel, MD
Dr. Wachtel has been a PI/Sub-PI in more than 41 multi-center research studies and authored numerous peered-reviewed publications. He has over 21 years of experience in Internal, Pulmonary, and Critical Care Medicine.
Cherylle Goebel
COO, CSO, Cofounder, and SAB. Cherylle has 20 years of project management and over 14 years of R&D experience in genomics and proteomics. She has worked for Kaiser, Thermo (Affymetrix/Pano), and UC Systems.
Christopher Louden
CIO, Cofounder, and SAB. He directs and evaluates statistical approaches for algorithm development and oversees IT operations.